Liver & Intestine Transplant Journal Articles

Risk of Hepatic and Extrahepatic Cancer in NAFLD This study investigated the risk of hepatic and extrahepatic cancer in patients with NAFLD compared to the general population.
Liver International, May 16, 2022
Medicaid Restriction Removal Increased HCV Treatment Rates Access to treatment improved after Medicaid-imposed restrictions were removed, but more policy changes are needed to address remaining disparities.
Journal of Viral Hepatitis, May 16, 2022
Overt HE in Cirrhotic Patients With Acute Decompensation This study aimed to determine whether the occurrence of overt hepatic encephalopathy is an independent risk factor for de novo infection in patients with cirrhosis and acute decompensation.
Alimentary Pharmacology & Therapeutics, April 27, 2022
Differentiating Focal Liver Lesions: ICC and HCC Review the use of contrast-enhanced magnetic resonance imaging as an important diagnostic tool in the evaluation of indeterminate liver lesions.
Applied Radiology, April 26, 2022
Incidence of HCV Related HCC in the Era of IFN-free Therapies This study examined trends over time of HCV-associated hepatocellular carcinoma. How has incidence changed since the introduction of IFN-free therapies?
Liver International, April 25, 2022
Immunosuppressive Drugs and COVID-19 Severity in AIH This study found that patients with autoimmune hepatitis who were taking certain immunosuppressants prior to the onset of COVID-19 had more severe courses of COVID-19.
Liver International, April 11, 2022
Hepatitis D Hospitalizations in the U.S.: 2010-2018 A new study provides insight into the hospitalization rates of hepatitis D in the U.S. and the various characteristics of these patients.
Journal of Viral Hepatitis, March 31, 2022
Prognosis of Patients With MAFLD by Non-invasive Methods Can non-invasive methods accurately predict global and liver-related mortality and morbidity in patients with MAFLD?
Alimentary Pharmacology & Therapeutics, March 29, 2022
Glycosylated 4-methylumbelliferone as Targeted Therapy for HCC This study found that glycosylation of 4MUR can improve its selectivity to tumor cells and may potentially be an effective targeted therapy for hepatocellular carcinoma.
Liver International, March 28, 2022
Liver-related and Extrahepatic Events in Patients With NAFLD This study evaluated the probability of developing liver-related events and extrahepatic events, considered as competing risks, in patients with NAFLD, stratified by fibrosis stage.
Alimentary Pharmacology & Therapeutics, March 24, 2022
Long-Term Prognosis in Alcohol-related Liver Disease or NAFLD Metabolic syndrome and alcohol use frequently co-exist. This study assessed survival in patients with NAFLD according to alcohol use and ALD according to the presence of metabolic syndrome.
Liver International, March 21, 2022
Cancer Risk in Patients With Autoimmune Hepatitis Do persons with autoimmune hepatitis have an increased risk of hepatic or extrahepatic cancers compared with the general population and siblings?
American Journal of Epidemiology, March 09, 2022
Novel Quantitative Ultrasound Technique for Identifying NASH The authors developed and validated a non-invasive tool based on quantitative ultrasound which provides a practical way of identifying the presence of NASH with and without early fibrosis.
Liver International, March 07, 2022
E-Nose vs Quadrupole Mass Spectrometry for Identifying HCV This study suggests that E-Nose technology can be an economical, easy-to-use, portable and non-invasive tool for screening and early diagnosis of HCV infection.
Journal of Viral Hepatitis, March 07, 2022
Acute Nonviral Hepatitis Linked to Alkaline Bottled Water This cluster of hepatitis of unknown etiology was traced to toxic exposure from one brand of bottled water, underscoring the importance of reporting unusual illnesses to public health authorities.
Morbidity & Mortality Weekly Report, February 09, 2022
Risk of HCC in Chronic Viral Hepatitis With Fatty Liver How does fatty liver impact the risk of hepatocellular carcinoma and mortality in patients with chronic viral hepatitis?
Alimentary Pharmacology & Therapeutics, February 01, 2022
Acute Coronary Syndrome in Patients With Liver Cirrhosis Review the management of patients with acute coronary syndrome and concurrent liver cirrhosis, which can be challenging due to hepatic activity of many antithrombotic drugs.
American Journal of Cardiovascular Drugs, February 01, 2022
Long-term Changes of Liver Stiffness in DAA Anti-HCV Therapy How does SVR impact the degree of fibrosis in the long-term after direct-acting antiviral HCV therapy? This study compared early vs. the long-term changes in liver stiffness that occur after therapy.
Journal of Viral Hepatitis, January 31, 2022
Robotic Donor Hepatectomy: A Major Breakthrough in LDLT Learn more about this breakthrough technology and how it could benefit living donor liver transplantation.
American Journal of Transplantation, January 20, 2022
Efficacy of an eConsult Service to Cure HCV in Primary Care This paper evaluated an eConsult system that provides individualized treatment recommendations from specially trained pharmacists and primary care physicians to other PCPs regarding HCV care.
Journal of Viral Hepatitis, January 17, 2022

No Results